In the presence of human carbonic anhydrase II, aryl-sulfonamide-bearing IrCp* pianostool complexes catalyze the asymmetric transfer hydrogenation of imines. Critical cofactor-protein interactions revealed by the X-ray structure of [(h 5 -Cp*)Ir(pico 4)Cl] 9 3 WT hCA II were genetically optimized to improve the catalytic performance of the artificial metalloenzyme (68% ee, k cat /K M 6.11 Â 10 À3 min À1 mM
Introduction
Articial metalloenzymes result from the incorporation of an organometallic moiety within a protein scaffold. In this context, three anchoring strategies have been pursued: covalent, supramolecular and dative. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] In the context of dative anchoring strategies, we hypothesized that human Carbonic Anhydrase II (hCA II hereaer) may provide a suitable scaffold for the creation of articial metalloenzymes. Indeed, para-substituted arylsulfonamides display high affinity for the catalytic Zn ion which lies at the bottom of a deep hydrophobic funnel-shaped cavity. We thus speculated that upon tethering an aryl-sulfonamide to a bidentate ligand may allow to anchor an organometallic catalyst within hCA II. 18 This was recently conrmed with an X-ray structure of an aryl-sulfonamide-bearing Ru pianostool complex incorporated within hCA II. 19, 20 However, this latter proved catalytically inactive for a variety of transformations. Herein we report on our efforts to create an articial transfer hydrogenase based on the incorporation of a catalytically active iridium pianostool complex within hCA II, Fig. 1 .
Results and discussion

Ligand synthesis
With the aim of identifying the most suitable scaffold for incorporation within hCA II, we set out to synthesize different ligands bearing a p-aryl-sulfonamide anchor. As previously demonstrated, the {IrCp*} 2+ moiety has proven superior to its {RhCp*} 2+ and {Ru(arene)} 2+ congeners for the reduction of imines in water. 21, 22 The synthesis of bis-pyridine 1, bipyridine 2, amino-pyridine 3 and sulfonamido-pyridine 4 and 5 ligands and the corresponding complexes 6-10 is presented in Schemes 1 and 2 (see ESI † for full experimental details).
The synthesis of bis-pyridine 1 was reported in 2011. 19 The preparation of bipy 2 started with an aldol condensation reaction between 4-(methylthio)benzaldehyde 11 and 2-acetylpyridine 12, to afford the corresponding phenyl-substitutedbipyridine 13. 23 The sulfonamide anchor was installed in three steps via oxidation of the thiomethyl function, 24 which was converted to the sulfonamide using the method disclosed by Zhang et al. 25 The sulfonamide-bearing bipyridine ligand 2 was obtained in 8% overall yield, Scheme 1.
The synthesis of 2-picolylamine-bearing ligand 3 relied on a palladium-catalyzed cross-coupling strategy as key step. Commercially available chloropyridine 14 and aryl-sulfonamide 15 were coupled under Suzuki conditions. Reduction of the nitrile with (AlCl 3 )$LiAlH 4 , followed by deprotection with TFA afforded the corresponding ligand 3 in 40% overall yield.
26,27
For the synthesis of ligands pico 4-H and pico 5-H, the oxime 17 was identied as advanced intermediate, easily accessed on large scale from commercially available 4-bromo-2-methylpyridine 16. Its synthesis was based on key steps starting from a Boekelheide reaction 28, 29 and followed by an oxidation to the corresponding aldehyde. 30 Treatment with hydroxylamine hydrochloride yielded the oxime 17. Reduction by Zn in triuoroacetic acid 31 followed by treatment with an aryl-sulfonylchloride derivative yielded the sulfonamide-pyridines 18 and 19, respectively.
32 Finally, the benzene sulfonamide anchor was introduced via Suzuki cross-coupling reaction to afford the bidentate ligands pico 4-H and pico 5-H in 5% overall yield.
33
The aminosulfonamide-bearing ligands 
Catalysis results
In order to evaluate the transfer hydrogenase activity of the pianostool complexes 6-10, the salsolidine precursor was selected as prochiral imine. 34 The sulfonamide-bearing catalysts 6-10 (1.8 mol% vs. imine, 5% DMSO in MOPS buffer, pH 7.5, 40 C, 20 hours, 150 eq. HCO 2 Na) were tested both in the absence and in the presence of hCA II (see ESI † for experimental details). From these data, it appears that both bispy-and bipybearing complexes [ Table 1 , entries 5 and 6). A recent report by Çetinkaya suggests that the transfer hydrogenase activity of d 6 -pianostool complexes with a sulfonamide-bearing 2-picolylamine is superior to that of the corresponding the 2-picolylamine-containing catalyst. 35 We thus set out to synthesize and evaluate the activity of [ These results highlight the critical inuence of the second coordination sphere interactions on the catalytic performance of pianostool complexes with a well dened rst coordination sphere.
With the aim of identifying critical residues in the most promising ATHase based on WT hCA II, the X-ray structure of [(h 5 -Cp*)Ir(pico 4)Cl] 9 3 hCA II was determined (vide infra, see Table 3 , entries [3] [4] [5] . This suggests that a secondary hydrophobic contact between the additional aryl group of the ligand and the hydrophobic funnel-shaped hCA II active site contributes to signicantly increase the affinity of these complexes. Fig. 2 .) Comparing the saturation kinetics behavior of the articial metalloenzyme with that of the organometallic catalyst demonstrates that the host protein has a major impact on the respective kinetic proles of the three catalysts.
X-ray structure of the hCA II metalloenzyme
To gain structural insight on the ATHase [(h 5 -Cp*)Ir(pico 4)Cl] 9 3 hCA II, diffraction data were collected to 1.3Å resolution of a hCA II crystal aer soaking in a solution of complex 9. Upon solving the crystal structure, residual density was apparent in the funnel-shaped active site of hCA II in close proximity to the catalytic zinc (Fig. 3) . The pyridine and terminal benzenesulfonamide moieties of complex 9 were modeled into the density with the sulfonamide forming a coordinative bond with the catalytic zinc and the benzene and pyridine ring arranged virtually coplanarly. A strong peak in both the F o -F c and the anomalous difference density map (23s and 8s, respectively) indicated the presence of the Ir atom in close proximity to the pyridine. The atom, however, is not fully occupied as found upon renement, which yielded 30% occupancy. The low occupancy may be due to partial dissociation of the metal upon complex binding to the protein. The iridium is coordinated by the pyridine nitrogen and the nitrogen of the secondary benzenesulfonamide. Consistent with the low occupancy, no electron density was observed for the Cp* ring, the chlorine, and the secondary benzenesulfonamide. In the nal model of the fully coordinated Ir atom the occupancy of these groups was set to 30%. Upon renement no negative density emerged in the F o -F c map. The pianostool moiety of the complex 9 is located in an hydrophobic groove formed by residues F131, V135, L198, P202 and L204. Residual density in the F o -F c omit map was encountered in proximity to the secondary benzenesulfonamide. Rotation of this group around the N py -C-C-N bond by 135 positions the sulfur atom in this density. Thus, upon dissociation of the iridium, the secondary benzenesulfonamide may undergo a conformational change from an eclipsed-to an anticlinalconformation. This would account for up to 70% of the total occupancy of the ligand (ESI Fig. S6 †) . In both, the eclipsed-and the anticlinal-conformation, the aromatic ring of the secondary benzenesulfonamide group is located in proximity to the side chains of E69, D72, I91 and F131. A qualitative model of the ATHase 9 3 hCA II in complex with the salsolidine precursor was constructed based on the structural and the functional data (Fig. 3) . The substrate binding site is constituted by complex 9 and residues H4, L60, N62, H64, K170 and G171, which, thus, are target amino acids for future genetic optimization of the ATHase (ESI Fig. S7 †) .
It is conceivable that the reduction of the side-chain-size in the I91A mutant changes the relative position of the substrate to the cofactor. However, it is not obvious from the X-ray structure how this abrogates the observed substrate inhibition.
Outlook
With the aim of creating articial transfer hydrogenases based on hCA II as protein scaffold, ve IrCp*-complexes bearing N^N bidentate ligands were screened. While the bare catalyst proved only moderately active, upon incorporation in hCA II, complex [(h 5 -Cp*)Ir(pico 4)Cl] 9 displayed signicantly improved catalytic performance both in terms of activity and selectivity at 4 C (up to 68% ee). Saturation kinetic analysis of the WT ATHase revealed however severe substrate inhibition. Guided by the Xray structure of complex [(h 5 -Cp*)Ir(pico 4)Cl] 9 3 WT hCA II, the catalytic site was expanded by mutation of close-lying isoleucine 91 into an alanine. This chemogenetically optimized ATHase [(h 5 -Cp*)Ir(pico 4)Cl] 9 3 I91A hCA II no longer suffered from substrate inhibition and displayed signicant rate enhancement over the organometallic catalyst. Current efforts are aimed at further engineering the catalytic site by genetic introduction of additional substrate recognition elements.
